Fei Xiong

1.3k total citations
39 papers, 526 citations indexed

About

Fei Xiong is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Fei Xiong has authored 39 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Fei Xiong's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (5 papers). Fei Xiong is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (5 papers). Fei Xiong collaborates with scholars based in China, United States and Netherlands. Fei Xiong's co-authors include Yongjun Chen, Guanhua Wu, Wenzheng Liu, Bing Wang, Qi Wang, Junsheng Chen, Junbin Chen, Longying Zha, Da Wang and Zhongdaixi Zheng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and Advanced Science.

In The Last Decade

Fei Xiong

37 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Xiong China 14 306 117 94 75 72 39 526
Liangzhi Wen China 11 300 1.0× 124 1.1× 95 1.0× 64 0.9× 77 1.1× 26 521
WEN-SHIN CHANG Taiwan 12 250 0.8× 158 1.4× 125 1.3× 53 0.7× 58 0.8× 74 527
Jufang Chi China 15 288 0.9× 79 0.7× 86 0.9× 47 0.6× 40 0.6× 26 579
Shan Cao China 15 412 1.3× 270 2.3× 95 1.0× 122 1.6× 59 0.8× 32 694
Xiaoming Huang China 14 329 1.1× 166 1.4× 119 1.3× 107 1.4× 33 0.5× 54 616
Xiaoqing Jia China 11 379 1.2× 173 1.5× 125 1.3× 110 1.5× 59 0.8× 36 587
Dan Kong China 14 306 1.0× 181 1.5× 78 0.8× 42 0.6× 42 0.6× 34 538

Countries citing papers authored by Fei Xiong

Since Specialization
Citations

This map shows the geographic impact of Fei Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiong more than expected).

Fields of papers citing papers by Fei Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiong. The network helps show where Fei Xiong may publish in the future.

Co-authorship network of co-authors of Fei Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Xiong. A scholar is included among the top collaborators of Fei Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Xiong. Fei Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Guanhua, Da Wang, Fei Xiong, et al.. (2024). The emerging roles of CEACAM6 in human cancer (Review). International Journal of Oncology. 64(3). 17 indexed citations
3.
Zheng, Zhongdaixi, Fengjuan Lin, Junbin Chen, et al.. (2023). Milk Exosomes from Gestational Diabetes Mellitus (GDM) and Healthy Parturient Exhibit Differential miRNAs Profiles and Distinct Regulatory Bioactivity on Hepatocyte Proliferation. Molecular Nutrition & Food Research. 67(16). e2300005–e2300005. 6 indexed citations
4.
Wang, Qi, Fei Xiong, Guanhua Wu, et al.. (2023). SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications. Diagnostics. 13(17). 2769–2769. 35 indexed citations
5.
Wu, Guanhua, Da Wang, Fei Xiong, et al.. (2023). Upregulation of RSPO3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma. Clinical Epigenetics. 15(1). 177–177. 2 indexed citations
6.
Wang, Da, Fei Xiong, Guanhua Wu, et al.. (2023). The value of total caudate lobe resection for hilar cholangiocarcinoma: a systematic review. International Journal of Surgery. 110(1). 385–394. 4 indexed citations
7.
Wu, Guanhua, Qi Wang, Da Wang, et al.. (2023). Targeting polycomb repressor complex 2‐mediated bivalent promoter epigenetic silencing of secreted frizzled‐related protein 1 inhibits cholangiocarcinoma progression. Clinical and Translational Medicine. 13(12). e1502–e1502. 6 indexed citations
8.
Wang, Zhen Zhen, Guo Yu, Zhu Xu, et al.. (2023). Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer. Journal of Translational Medicine. 21(1). 615–615. 4 indexed citations
9.
Liu, Wenzheng, Fei Xiong, Guanhua Wu, et al.. (2023). Biliary-enteric reconstruction in laparoscopic radical resection of hilar cholangiocarcinoma: a single-center retrospective cohort study. BMC Cancer. 23(1). 456–456. 2 indexed citations
10.
Xiong, Fei, et al.. (2022). Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma. Disease Markers. 2022. 1–25. 6 indexed citations
11.
Wang, Sheng, et al.. (2022). Single-port thoracoscopic resection of a posterior mediastinal Mullerian cyst in a woman. Journal of International Medical Research. 50(5). 3629157203–3629157203. 1 indexed citations
12.
Xiong, Fei, Qi Wang, Guanhua Wu, et al.. (2022). Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow. Biomarker Research. 10(1). 69–69. 24 indexed citations
13.
Wang, Qi, Yongqiang Qi, Fei Xiong, et al.. (2022). The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells. BMC Cancer. 22(1). 1166–1166. 1 indexed citations
15.
Chen, Junbin, et al.. (2020). Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts. BMC Complementary Medicine and Therapies. 20(1). 167–167. 28 indexed citations
16.
Chen, Junbin, et al.. (2020). Soyasaponin A1 Inhibits the Lipid Raft Recruitment and Dimerization of TLR4, MyD88 and TRIF in Palmitate-Stimulated Inflammatory Macrophages. Current Developments in Nutrition. 4. nzaa068_007–nzaa068_007. 1 indexed citations
17.
Zhang, Jing, Longmin Chen, Fei Xiong, et al.. (2019). Autophagy in regulatory T cells: A double-edged sword in disease settings. Molecular Immunology. 109. 43–50. 20 indexed citations
18.
Hutchison, Colin A., Fei Xiong, & Peter Mollee. (2017). The treatment of paraprotein-related kidney disease. Current Opinion in Nephrology & Hypertension. 26(6). 477–483. 2 indexed citations
19.
Tu, Yaqin, Ping Yang, Jia Yang, et al.. (2014). Clinical and genetic characteristics for the Urofacial Syndrome (UFS).. PubMed. 7(5). 1842–8. 8 indexed citations
20.
Liu, Zhi, Fei Xiong, Dongliang Li, et al.. (2012). Effect of Fixation and Staining Methods on Structure Observation of Endosperm Cell of Wheat. ACTA AGRONOMICA SINICA. 38(9). 1688–1697. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026